| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.00096 | 1 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.0051 | 1 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00099 | 1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.00096 | 1 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.00069 | 1 |